nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—osteoarthritis—Prednisone—prostate cancer	0.224	1	CpDpCtD
Lidocaine—CYP2C18—prostate cancer	0.0879	0.297	CbGaD
Lidocaine—EGFR—prostate cancer	0.0686	0.232	CbGaD
Lidocaine—CYP3A5—prostate cancer	0.0579	0.196	CbGaD
Lidocaine—CYP2A6—prostate cancer	0.056	0.19	CbGaD
Lidocaine—EGFR—Docetaxel—prostate cancer	0.029	0.0958	CbGbCtD
Lidocaine—CYP3A4—prostate cancer	0.0251	0.0848	CbGaD
Lidocaine—CYP2C8—Nilutamide—prostate cancer	0.0124	0.041	CbGbCtD
Lidocaine—CYP3A5—Flutamide—prostate cancer	0.0107	0.0353	CbGbCtD
Lidocaine—CYP2C8—Abiraterone—prostate cancer	0.0103	0.034	CbGbCtD
Lidocaine—CYP2B6—Estrone—prostate cancer	0.0098	0.0324	CbGbCtD
Lidocaine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00957	0.0317	CbGbCtD
Lidocaine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00873	0.0289	CbGbCtD
Lidocaine—CYP2C9—Bicalutamide—prostate cancer	0.00864	0.0286	CbGbCtD
Lidocaine—CYP2C9—Nilutamide—prostate cancer	0.00864	0.0286	CbGbCtD
Lidocaine—CYP1A2—Flutamide—prostate cancer	0.00795	0.0263	CbGbCtD
Lidocaine—CYP2D6—Bicalutamide—prostate cancer	0.0079	0.0262	CbGbCtD
Lidocaine—CYP3A5—Cabazitaxel—prostate cancer	0.0079	0.0261	CbGbCtD
Lidocaine—ABCB1—Estramustine—prostate cancer	0.0078	0.0258	CbGbCtD
Lidocaine—CYP3A5—Estrone—prostate cancer	0.00772	0.0255	CbGbCtD
Lidocaine—CYP2C8—Cabazitaxel—prostate cancer	0.00759	0.0251	CbGbCtD
Lidocaine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00662	0.0219	CbGbCtD
Lidocaine—CYP2D6—Abiraterone—prostate cancer	0.00655	0.0217	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00591	0.0196	CbGbCtD
Lidocaine—CYP3A7—Estradiol—prostate cancer	0.00591	0.0196	CbGbCtD
Lidocaine—CYP1A2—Estrone—prostate cancer	0.00575	0.019	CbGbCtD
Lidocaine—CYP2C9—Estrone—prostate cancer	0.00518	0.0171	CbGbCtD
Lidocaine—ABCB1—Cabazitaxel—prostate cancer	0.00514	0.017	CbGbCtD
Lidocaine—CYP3A4—Bicalutamide—prostate cancer	0.00503	0.0166	CbGbCtD
Lidocaine—ABCB1—Estrone—prostate cancer	0.00502	0.0166	CbGbCtD
Lidocaine—CYP3A4—Estramustine—prostate cancer	0.00467	0.0155	CbGbCtD
Lidocaine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00448	0.0148	CbGbCtD
Lidocaine—CYP3A5—Estradiol—prostate cancer	0.00443	0.0147	CbGbCtD
Lidocaine—CYP2C8—Estradiol—prostate cancer	0.00426	0.0141	CbGbCtD
Lidocaine—CYP3A4—Abiraterone—prostate cancer	0.00416	0.0138	CbGbCtD
Lidocaine—CYP3A4—Flutamide—prostate cancer	0.00416	0.0138	CbGbCtD
Lidocaine—CYP2C9—Capecitabine—prostate cancer	0.00392	0.013	CbGbCtD
Lidocaine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00376	0.0124	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00353	0.0117	CbGbCtD
Lidocaine—CYP3A7—Docetaxel—prostate cancer	0.00353	0.0117	CbGbCtD
Lidocaine—CYP1A2—Estradiol—prostate cancer	0.0033	0.0109	CbGbCtD
Lidocaine—ABCB1—Conjugated Estrogens—prostate cancer	0.00329	0.0109	CbGbCtD
Lidocaine—CYP3A4—Cabazitaxel—prostate cancer	0.00308	0.0102	CbGbCtD
Lidocaine—CYP3A4—Estrone—prostate cancer	0.00301	0.00996	CbGbCtD
Lidocaine—ABCB1—Mitoxantrone—prostate cancer	0.00299	0.00989	CbGbCtD
Lidocaine—CYP2C9—Estradiol—prostate cancer	0.00297	0.00984	CbGbCtD
Lidocaine—CYP3A5—Etoposide—prostate cancer	0.0029	0.00958	CbGbCtD
Lidocaine—ABCB1—Estradiol—prostate cancer	0.00289	0.00955	CbGbCtD
Lidocaine—CYP2C8—Etoposide—prostate cancer	0.00278	0.00921	CbGbCtD
Lidocaine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00268	0.00888	CbGbCtD
Lidocaine—CYP3A5—Docetaxel—prostate cancer	0.00265	0.00877	CbGbCtD
Lidocaine—CYP2B6—Doxorubicin—prostate cancer	0.00251	0.0083	CbGbCtD
Lidocaine—ABCB1—Prednisone—prostate cancer	0.00248	0.00821	CbGbCtD
Lidocaine—CYP1A2—Etoposide—prostate cancer	0.00215	0.00713	CbGbCtD
Lidocaine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00197	0.00652	CbGbCtD
Lidocaine—ABCB1—Etoposide—prostate cancer	0.00188	0.00624	CbGbCtD
Lidocaine—CYP3A4—Mitoxantrone—prostate cancer	0.00179	0.00592	CbGbCtD
Lidocaine—CYP3A4—Estradiol—prostate cancer	0.00173	0.00572	CbGbCtD
Lidocaine—ABCB1—Docetaxel—prostate cancer	0.00172	0.00571	CbGbCtD
Lidocaine—CYP3A4—Prednisone—prostate cancer	0.00149	0.00492	CbGbCtD
Lidocaine—ABCB1—Doxorubicin—prostate cancer	0.00129	0.00425	CbGbCtD
Lidocaine—CYP2D6—Doxorubicin—prostate cancer	0.00121	0.00401	CbGbCtD
Lidocaine—CYP3A4—Etoposide—prostate cancer	0.00113	0.00374	CbGbCtD
Lidocaine—EGFR—prostate gland—prostate cancer	0.00112	0.0694	CbGeAlD
Lidocaine—CYP3A4—Docetaxel—prostate cancer	0.00103	0.00342	CbGbCtD
Lidocaine—CYP1A2—urine—prostate cancer	0.000939	0.058	CbGeAlD
Lidocaine—SCN9A—prostate gland—prostate cancer	0.000925	0.0571	CbGeAlD
Lidocaine—CYP2C9—urine—prostate cancer	0.000891	0.055	CbGeAlD
Lidocaine—SCN4A—prostate gland—prostate cancer	0.000825	0.051	CbGeAlD
Lidocaine—CYP3A4—Doxorubicin—prostate cancer	0.00077	0.00255	CbGbCtD
Lidocaine—CYP3A4—urine—prostate cancer	0.000679	0.042	CbGeAlD
Lidocaine—CYP2D6—urine—prostate cancer	0.000669	0.0413	CbGeAlD
Lidocaine—SCN3A—prostate gland—prostate cancer	0.000642	0.0397	CbGeAlD
Lidocaine—CYP2A6—prostate gland—prostate cancer	0.000641	0.0396	CbGeAlD
Lidocaine—SCN4A—renal system—prostate cancer	0.000562	0.0347	CbGeAlD
Lidocaine—CYP2A6—seminal vesicle—prostate cancer	0.000543	0.0335	CbGeAlD
Lidocaine—EGFR—testis—prostate cancer	0.000495	0.0306	CbGeAlD
Lidocaine—SCN3A—renal system—prostate cancer	0.000438	0.027	CbGeAlD
Lidocaine—SCN9A—testis—prostate cancer	0.000408	0.0252	CbGeAlD
Lidocaine—SLC22A5—prostate gland—prostate cancer	0.000372	0.023	CbGeAlD
Lidocaine—SCN4A—testis—prostate cancer	0.000364	0.0225	CbGeAlD
Lidocaine—EGFR—lymph node—prostate cancer	0.000359	0.0222	CbGeAlD
Lidocaine—SCN3A—bone marrow—prostate cancer	0.000331	0.0204	CbGeAlD
Lidocaine—Procainamide—DNMT1—prostate cancer	0.000326	0.231	CrCbGaD
Lidocaine—CYP3A5—prostate gland—prostate cancer	0.000325	0.0201	CbGeAlD
Lidocaine—SLC22A5—seminal vesicle—prostate cancer	0.000315	0.0194	CbGeAlD
Lidocaine—SCN9A—lymph node—prostate cancer	0.000295	0.0182	CbGeAlD
Lidocaine—SCN3A—testis—prostate cancer	0.000283	0.0175	CbGeAlD
Lidocaine—SLC22A5—renal system—prostate cancer	0.000254	0.0157	CbGeAlD
Lidocaine—SLC22A5—urethra—prostate cancer	0.000249	0.0154	CbGeAlD
Lidocaine—CYP2C8—renal system—prostate cancer	0.000245	0.0152	CbGeAlD
Lidocaine—CYP1A2—renal system—prostate cancer	0.00023	0.0142	CbGeAlD
Lidocaine—SCN10A—lymph node—prostate cancer	0.000225	0.0139	CbGeAlD
Lidocaine—CYP3A5—renal system—prostate cancer	0.000222	0.0137	CbGeAlD
Lidocaine—CYP2B6—renal system—prostate cancer	0.00022	0.0136	CbGeAlD
Lidocaine—Procainamide—SLC22A3—prostate cancer	0.000213	0.151	CrCbGaD
Lidocaine—SCN3A—lymph node—prostate cancer	0.000205	0.0127	CbGeAlD
Lidocaine—Procainamide—ACHE—prostate cancer	0.000193	0.137	CrCbGaD
Lidocaine—Bupivacaine—CYP2C19—prostate cancer	0.000179	0.127	CrCbGaD
Lidocaine—ABCB1—prostate gland—prostate cancer	0.000173	0.0107	CbGeAlD
Lidocaine—CYP3A4—renal system—prostate cancer	0.000166	0.0103	CbGeAlD
Lidocaine—SLC22A5—testis—prostate cancer	0.000164	0.0101	CbGeAlD
Lidocaine—CYP2D6—renal system—prostate cancer	0.000164	0.0101	CbGeAlD
Lidocaine—CYP2C8—testis—prostate cancer	0.000159	0.0098	CbGeAlD
Lidocaine—Procainamide—SLC22A1—prostate cancer	0.000153	0.108	CrCbGaD
Lidocaine—ABCB1—seminal vesicle—prostate cancer	0.000146	0.00902	CbGeAlD
Lidocaine—Levobupivacaine—CYP3A4—prostate cancer	0.000143	0.101	CrCbGaD
Lidocaine—CYP2B6—testis—prostate cancer	0.000142	0.00879	CbGeAlD
Lidocaine—ABCB1—epithelium—prostate cancer	0.000127	0.00784	CbGeAlD
Lidocaine—SLC22A5—lymph node—prostate cancer	0.000119	0.00734	CbGeAlD
Lidocaine—ABCB1—renal system—prostate cancer	0.000118	0.00727	CbGeAlD
Lidocaine—ABCB1—urethra—prostate cancer	0.000116	0.00714	CbGeAlD
Lidocaine—Bupivacaine—CYP3A4—prostate cancer	0.000114	0.0807	CrCbGaD
Lidocaine—CYP2D6—testis—prostate cancer	0.000106	0.00653	CbGeAlD
Lidocaine—Ropivacaine—CYP3A4—prostate cancer	9.2e-05	0.0651	CrCbGaD
Lidocaine—ABCB1—bone marrow—prostate cancer	8.9e-05	0.0055	CbGeAlD
Lidocaine—ABCB1—testis—prostate cancer	7.61e-05	0.0047	CbGeAlD
Lidocaine—ABCB1—lymph node—prostate cancer	5.51e-05	0.00341	CbGeAlD
Lidocaine—Tinnitus—Capecitabine—prostate cancer	4.63e-05	0.000587	CcSEcCtD
Lidocaine—Osteoarthritis—Doxorubicin—prostate cancer	4.63e-05	0.000587	CcSEcCtD
Lidocaine—Diplopia—Doxorubicin—prostate cancer	4.63e-05	0.000587	CcSEcCtD
Lidocaine—Flushing—Capecitabine—prostate cancer	4.61e-05	0.000584	CcSEcCtD
Lidocaine—Cardiac disorder—Capecitabine—prostate cancer	4.61e-05	0.000584	CcSEcCtD
Lidocaine—Chills—Docetaxel—prostate cancer	4.6e-05	0.000584	CcSEcCtD
Lidocaine—Chest pain—Etoposide—prostate cancer	4.57e-05	0.00058	CcSEcCtD
Lidocaine—Vomiting—Goserelin—prostate cancer	4.54e-05	0.000575	CcSEcCtD
Lidocaine—Pain—Mitoxantrone—prostate cancer	4.51e-05	0.000572	CcSEcCtD
Lidocaine—Angiopathy—Capecitabine—prostate cancer	4.51e-05	0.000571	CcSEcCtD
Lidocaine—Bradycardia—Prednisone—prostate cancer	4.5e-05	0.000571	CcSEcCtD
Lidocaine—Rash—Goserelin—prostate cancer	4.5e-05	0.000571	CcSEcCtD
Lidocaine—Dermatitis—Goserelin—prostate cancer	4.5e-05	0.00057	CcSEcCtD
Lidocaine—Vomiting—Conjugated Estrogens—prostate cancer	4.5e-05	0.00057	CcSEcCtD
Lidocaine—Urticaria—Estradiol—prostate cancer	4.5e-05	0.00057	CcSEcCtD
Lidocaine—Immune system disorder—Capecitabine—prostate cancer	4.49e-05	0.000569	CcSEcCtD
Lidocaine—Headache—Goserelin—prostate cancer	4.47e-05	0.000567	CcSEcCtD
Lidocaine—Erythema—Docetaxel—prostate cancer	4.47e-05	0.000566	CcSEcCtD
Lidocaine—Rash—Conjugated Estrogens—prostate cancer	4.46e-05	0.000565	CcSEcCtD
Lidocaine—Chills—Capecitabine—prostate cancer	4.46e-05	0.000565	CcSEcCtD
Lidocaine—Dermatitis—Conjugated Estrogens—prostate cancer	4.45e-05	0.000565	CcSEcCtD
Lidocaine—Haemoglobin—Prednisone—prostate cancer	4.45e-05	0.000564	CcSEcCtD
Lidocaine—Headache—Conjugated Estrogens—prostate cancer	4.43e-05	0.000562	CcSEcCtD
Lidocaine—Haemorrhage—Prednisone—prostate cancer	4.42e-05	0.000561	CcSEcCtD
Lidocaine—Confusional state—Etoposide—prostate cancer	4.42e-05	0.000561	CcSEcCtD
Lidocaine—Cardiac arrest—Doxorubicin—prostate cancer	4.4e-05	0.000558	CcSEcCtD
Lidocaine—Anaphylactic shock—Etoposide—prostate cancer	4.39e-05	0.000556	CcSEcCtD
Lidocaine—Dysgeusia—Docetaxel—prostate cancer	4.37e-05	0.000554	CcSEcCtD
Lidocaine—Feeling abnormal—Mitoxantrone—prostate cancer	4.34e-05	0.000551	CcSEcCtD
Lidocaine—Erythema—Capecitabine—prostate cancer	4.32e-05	0.000548	CcSEcCtD
Lidocaine—Asthma—Epirubicin—prostate cancer	4.32e-05	0.000548	CcSEcCtD
Lidocaine—Dysphagia—Epirubicin—prostate cancer	4.32e-05	0.000548	CcSEcCtD
Lidocaine—Back pain—Docetaxel—prostate cancer	4.32e-05	0.000548	CcSEcCtD
Lidocaine—Nausea—Goserelin—prostate cancer	4.24e-05	0.000538	CcSEcCtD
Lidocaine—Hyperhidrosis—Etoposide—prostate cancer	4.24e-05	0.000538	CcSEcCtD
Lidocaine—Dysgeusia—Capecitabine—prostate cancer	4.23e-05	0.000537	CcSEcCtD
Lidocaine—Nausea—Conjugated Estrogens—prostate cancer	4.2e-05	0.000532	CcSEcCtD
Lidocaine—Urticaria—Mitoxantrone—prostate cancer	4.19e-05	0.000531	CcSEcCtD
Lidocaine—Back pain—Capecitabine—prostate cancer	4.18e-05	0.00053	CcSEcCtD
Lidocaine—Hypersensitivity—Estradiol—prostate cancer	4.17e-05	0.000529	CcSEcCtD
Lidocaine—Eye disorder—Prednisone—prostate cancer	4.13e-05	0.000524	CcSEcCtD
Lidocaine—Flushing—Prednisone—prostate cancer	4.11e-05	0.000521	CcSEcCtD
Lidocaine—Hypotension—Etoposide—prostate cancer	4.1e-05	0.00052	CcSEcCtD
Lidocaine—Vision blurred—Capecitabine—prostate cancer	4.07e-05	0.000517	CcSEcCtD
Lidocaine—Asthenia—Estradiol—prostate cancer	4.06e-05	0.000515	CcSEcCtD
Lidocaine—Tremor—Capecitabine—prostate cancer	4.05e-05	0.000514	CcSEcCtD
Lidocaine—Angiopathy—Prednisone—prostate cancer	4.01e-05	0.000509	CcSEcCtD
Lidocaine—Dysphagia—Doxorubicin—prostate cancer	4e-05	0.000507	CcSEcCtD
Lidocaine—Asthma—Doxorubicin—prostate cancer	4e-05	0.000507	CcSEcCtD
Lidocaine—Immune system disorder—Prednisone—prostate cancer	4e-05	0.000507	CcSEcCtD
Lidocaine—Paraesthesia—Etoposide—prostate cancer	3.94e-05	0.000499	CcSEcCtD
Lidocaine—Loss of consciousness—Docetaxel—prostate cancer	3.92e-05	0.000498	CcSEcCtD
Lidocaine—Dyspnoea—Etoposide—prostate cancer	3.91e-05	0.000496	CcSEcCtD
Lidocaine—Somnolence—Etoposide—prostate cancer	3.9e-05	0.000494	CcSEcCtD
Lidocaine—Hypersensitivity—Mitoxantrone—prostate cancer	3.88e-05	0.000493	CcSEcCtD
Lidocaine—Convulsion—Docetaxel—prostate cancer	3.87e-05	0.000491	CcSEcCtD
Lidocaine—Hypertension—Docetaxel—prostate cancer	3.86e-05	0.000489	CcSEcCtD
Lidocaine—Drowsiness—Epirubicin—prostate cancer	3.85e-05	0.000489	CcSEcCtD
Lidocaine—Erythema—Prednisone—prostate cancer	3.85e-05	0.000488	CcSEcCtD
Lidocaine—Chest pain—Docetaxel—prostate cancer	3.8e-05	0.000482	CcSEcCtD
Lidocaine—Loss of consciousness—Capecitabine—prostate cancer	3.8e-05	0.000482	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Etoposide—prostate cancer	3.79e-05	0.00048	CcSEcCtD
Lidocaine—Asthenia—Mitoxantrone—prostate cancer	3.78e-05	0.00048	CcSEcCtD
Lidocaine—Neuropathy peripheral—Epirubicin—prostate cancer	3.78e-05	0.000479	CcSEcCtD
Lidocaine—Stomatitis—Epirubicin—prostate cancer	3.76e-05	0.000476	CcSEcCtD
Lidocaine—Pain—Etoposide—prostate cancer	3.75e-05	0.000476	CcSEcCtD
Lidocaine—Dizziness—Estradiol—prostate cancer	3.74e-05	0.000474	CcSEcCtD
Lidocaine—Hypertension—Capecitabine—prostate cancer	3.73e-05	0.000473	CcSEcCtD
Lidocaine—Chest pain—Capecitabine—prostate cancer	3.68e-05	0.000467	CcSEcCtD
Lidocaine—Confusional state—Docetaxel—prostate cancer	3.67e-05	0.000466	CcSEcCtD
Lidocaine—Anxiety—Capecitabine—prostate cancer	3.67e-05	0.000465	CcSEcCtD
Lidocaine—Oedema—Docetaxel—prostate cancer	3.64e-05	0.000462	CcSEcCtD
Lidocaine—Anaphylactic shock—Docetaxel—prostate cancer	3.64e-05	0.000462	CcSEcCtD
Lidocaine—Vision blurred—Prednisone—prostate cancer	3.63e-05	0.00046	CcSEcCtD
Lidocaine—Feeling abnormal—Etoposide—prostate cancer	3.61e-05	0.000458	CcSEcCtD
Lidocaine—Vomiting—Estradiol—prostate cancer	3.6e-05	0.000456	CcSEcCtD
Lidocaine—Shock—Docetaxel—prostate cancer	3.59e-05	0.000455	CcSEcCtD
Lidocaine—Nervous system disorder—Docetaxel—prostate cancer	3.57e-05	0.000453	CcSEcCtD
Lidocaine—Rash—Estradiol—prostate cancer	3.57e-05	0.000452	CcSEcCtD
Lidocaine—Drowsiness—Doxorubicin—prostate cancer	3.57e-05	0.000452	CcSEcCtD
Lidocaine—Dermatitis—Estradiol—prostate cancer	3.56e-05	0.000452	CcSEcCtD
Lidocaine—Confusional state—Capecitabine—prostate cancer	3.56e-05	0.000451	CcSEcCtD
Lidocaine—Headache—Estradiol—prostate cancer	3.54e-05	0.000449	CcSEcCtD
Lidocaine—Agitation—Prednisone—prostate cancer	3.54e-05	0.000449	CcSEcCtD
Lidocaine—Oedema—Capecitabine—prostate cancer	3.53e-05	0.000447	CcSEcCtD
Lidocaine—Bradycardia—Epirubicin—prostate cancer	3.52e-05	0.000447	CcSEcCtD
Lidocaine—Angioedema—Prednisone—prostate cancer	3.52e-05	0.000446	CcSEcCtD
Lidocaine—Neuropathy peripheral—Doxorubicin—prostate cancer	3.5e-05	0.000443	CcSEcCtD
Lidocaine—Urticaria—Etoposide—prostate cancer	3.48e-05	0.000442	CcSEcCtD
Lidocaine—Haemoglobin—Epirubicin—prostate cancer	3.48e-05	0.000441	CcSEcCtD
Lidocaine—Stomatitis—Doxorubicin—prostate cancer	3.48e-05	0.000441	CcSEcCtD
Lidocaine—Shock—Capecitabine—prostate cancer	3.47e-05	0.00044	CcSEcCtD
Lidocaine—Rhinitis—Epirubicin—prostate cancer	3.47e-05	0.00044	CcSEcCtD
Lidocaine—Nervous system disorder—Capecitabine—prostate cancer	3.46e-05	0.000439	CcSEcCtD
Lidocaine—Haemorrhage—Epirubicin—prostate cancer	3.46e-05	0.000439	CcSEcCtD
Lidocaine—Hypoaesthesia—Epirubicin—prostate cancer	3.44e-05	0.000437	CcSEcCtD
Lidocaine—Hyperhidrosis—Capecitabine—prostate cancer	3.41e-05	0.000433	CcSEcCtD
Lidocaine—Hypotension—Docetaxel—prostate cancer	3.41e-05	0.000432	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisone—prostate cancer	3.38e-05	0.000429	CcSEcCtD
Lidocaine—Nausea—Estradiol—prostate cancer	3.36e-05	0.000426	CcSEcCtD
Lidocaine—Vomiting—Mitoxantrone—prostate cancer	3.35e-05	0.000425	CcSEcCtD
Lidocaine—Convulsion—Prednisone—prostate cancer	3.34e-05	0.000423	CcSEcCtD
Lidocaine—Visual impairment—Epirubicin—prostate cancer	3.33e-05	0.000423	CcSEcCtD
Lidocaine—Hypertension—Prednisone—prostate cancer	3.32e-05	0.000422	CcSEcCtD
Lidocaine—Rash—Mitoxantrone—prostate cancer	3.32e-05	0.000422	CcSEcCtD
Lidocaine—Dermatitis—Mitoxantrone—prostate cancer	3.32e-05	0.000421	CcSEcCtD
Lidocaine—Headache—Mitoxantrone—prostate cancer	3.3e-05	0.000419	CcSEcCtD
Lidocaine—Hypotension—Capecitabine—prostate cancer	3.3e-05	0.000418	CcSEcCtD
Lidocaine—Paraesthesia—Docetaxel—prostate cancer	3.27e-05	0.000415	CcSEcCtD
Lidocaine—Anxiety—Prednisone—prostate cancer	3.27e-05	0.000414	CcSEcCtD
Lidocaine—Bradycardia—Doxorubicin—prostate cancer	3.26e-05	0.000413	CcSEcCtD
Lidocaine—Dyspnoea—Docetaxel—prostate cancer	3.25e-05	0.000412	CcSEcCtD
Lidocaine—Somnolence—Docetaxel—prostate cancer	3.24e-05	0.000411	CcSEcCtD
Lidocaine—Eye disorder—Epirubicin—prostate cancer	3.23e-05	0.00041	CcSEcCtD
Lidocaine—Hypersensitivity—Etoposide—prostate cancer	3.23e-05	0.00041	CcSEcCtD
Lidocaine—Tinnitus—Epirubicin—prostate cancer	3.23e-05	0.000409	CcSEcCtD
Lidocaine—Haemoglobin—Doxorubicin—prostate cancer	3.22e-05	0.000408	CcSEcCtD
Lidocaine—Cardiac disorder—Epirubicin—prostate cancer	3.21e-05	0.000407	CcSEcCtD
Lidocaine—Flushing—Epirubicin—prostate cancer	3.21e-05	0.000407	CcSEcCtD
Lidocaine—Rhinitis—Doxorubicin—prostate cancer	3.21e-05	0.000407	CcSEcCtD
Lidocaine—Haemorrhage—Doxorubicin—prostate cancer	3.2e-05	0.000406	CcSEcCtD
Lidocaine—Hypoaesthesia—Doxorubicin—prostate cancer	3.19e-05	0.000404	CcSEcCtD
Lidocaine—Paraesthesia—Capecitabine—prostate cancer	3.17e-05	0.000402	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.15e-05	0.000399	CcSEcCtD
Lidocaine—Asthenia—Etoposide—prostate cancer	3.15e-05	0.000399	CcSEcCtD
Lidocaine—Dyspnoea—Capecitabine—prostate cancer	3.15e-05	0.000399	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisone—prostate cancer	3.14e-05	0.000399	CcSEcCtD
Lidocaine—Oedema—Prednisone—prostate cancer	3.14e-05	0.000399	CcSEcCtD
Lidocaine—Angiopathy—Epirubicin—prostate cancer	3.14e-05	0.000398	CcSEcCtD
Lidocaine—Nausea—Mitoxantrone—prostate cancer	3.13e-05	0.000397	CcSEcCtD
Lidocaine—Immune system disorder—Epirubicin—prostate cancer	3.13e-05	0.000396	CcSEcCtD
Lidocaine—Pain—Docetaxel—prostate cancer	3.12e-05	0.000395	CcSEcCtD
Lidocaine—Chills—Epirubicin—prostate cancer	3.1e-05	0.000394	CcSEcCtD
Lidocaine—Shock—Prednisone—prostate cancer	3.09e-05	0.000392	CcSEcCtD
Lidocaine—Visual impairment—Doxorubicin—prostate cancer	3.09e-05	0.000391	CcSEcCtD
Lidocaine—Nervous system disorder—Prednisone—prostate cancer	3.08e-05	0.000391	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Capecitabine—prostate cancer	3.05e-05	0.000386	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisone—prostate cancer	3.04e-05	0.000385	CcSEcCtD
Lidocaine—Pain—Capecitabine—prostate cancer	3.02e-05	0.000383	CcSEcCtD
Lidocaine—Erythema—Epirubicin—prostate cancer	3.01e-05	0.000382	CcSEcCtD
Lidocaine—Feeling abnormal—Docetaxel—prostate cancer	3e-05	0.000381	CcSEcCtD
Lidocaine—Eye disorder—Doxorubicin—prostate cancer	2.99e-05	0.000379	CcSEcCtD
Lidocaine—Tinnitus—Doxorubicin—prostate cancer	2.98e-05	0.000378	CcSEcCtD
Lidocaine—Cardiac disorder—Doxorubicin—prostate cancer	2.97e-05	0.000377	CcSEcCtD
Lidocaine—Flushing—Doxorubicin—prostate cancer	2.97e-05	0.000377	CcSEcCtD
Lidocaine—Tension—Epirubicin—prostate cancer	2.96e-05	0.000375	CcSEcCtD
Lidocaine—Dysgeusia—Epirubicin—prostate cancer	2.95e-05	0.000374	CcSEcCtD
Lidocaine—Nervousness—Epirubicin—prostate cancer	2.93e-05	0.000371	CcSEcCtD
Lidocaine—Back pain—Epirubicin—prostate cancer	2.91e-05	0.000369	CcSEcCtD
Lidocaine—Feeling abnormal—Capecitabine—prostate cancer	2.91e-05	0.000369	CcSEcCtD
Lidocaine—Angiopathy—Doxorubicin—prostate cancer	2.9e-05	0.000368	CcSEcCtD
Lidocaine—Dizziness—Etoposide—prostate cancer	2.9e-05	0.000368	CcSEcCtD
Lidocaine—Immune system disorder—Doxorubicin—prostate cancer	2.89e-05	0.000367	CcSEcCtD
Lidocaine—Chills—Doxorubicin—prostate cancer	2.87e-05	0.000364	CcSEcCtD
Lidocaine—Vision blurred—Epirubicin—prostate cancer	2.84e-05	0.00036	CcSEcCtD
Lidocaine—Paraesthesia—Prednisone—prostate cancer	2.82e-05	0.000358	CcSEcCtD
Lidocaine—Urticaria—Capecitabine—prostate cancer	2.8e-05	0.000355	CcSEcCtD
Lidocaine—Vomiting—Etoposide—prostate cancer	2.79e-05	0.000354	CcSEcCtD
Lidocaine—Erythema—Doxorubicin—prostate cancer	2.79e-05	0.000353	CcSEcCtD
Lidocaine—Agitation—Epirubicin—prostate cancer	2.77e-05	0.000351	CcSEcCtD
Lidocaine—Rash—Etoposide—prostate cancer	2.77e-05	0.000351	CcSEcCtD
Lidocaine—Dermatitis—Etoposide—prostate cancer	2.76e-05	0.00035	CcSEcCtD
Lidocaine—Headache—Etoposide—prostate cancer	2.75e-05	0.000348	CcSEcCtD
Lidocaine—Tension—Doxorubicin—prostate cancer	2.73e-05	0.000347	CcSEcCtD
Lidocaine—Dysgeusia—Doxorubicin—prostate cancer	2.73e-05	0.000346	CcSEcCtD
Lidocaine—Nervousness—Doxorubicin—prostate cancer	2.71e-05	0.000343	CcSEcCtD
Lidocaine—Back pain—Doxorubicin—prostate cancer	2.7e-05	0.000342	CcSEcCtD
Lidocaine—Hypersensitivity—Docetaxel—prostate cancer	2.69e-05	0.00034	CcSEcCtD
Lidocaine—Loss of consciousness—Epirubicin—prostate cancer	2.65e-05	0.000336	CcSEcCtD
Lidocaine—Vision blurred—Doxorubicin—prostate cancer	2.63e-05	0.000333	CcSEcCtD
Lidocaine—Asthenia—Docetaxel—prostate cancer	2.61e-05	0.000332	CcSEcCtD
Lidocaine—Convulsion—Epirubicin—prostate cancer	2.61e-05	0.000331	CcSEcCtD
Lidocaine—Nausea—Etoposide—prostate cancer	2.6e-05	0.00033	CcSEcCtD
Lidocaine—Hypertension—Epirubicin—prostate cancer	2.6e-05	0.00033	CcSEcCtD
Lidocaine—Hypersensitivity—Capecitabine—prostate cancer	2.6e-05	0.00033	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisone—prostate cancer	2.59e-05	0.000328	CcSEcCtD
Lidocaine—Chest pain—Epirubicin—prostate cancer	2.56e-05	0.000325	CcSEcCtD
Lidocaine—Agitation—Doxorubicin—prostate cancer	2.56e-05	0.000325	CcSEcCtD
Lidocaine—Anxiety—Epirubicin—prostate cancer	2.56e-05	0.000324	CcSEcCtD
Lidocaine—Asthenia—Capecitabine—prostate cancer	2.53e-05	0.000321	CcSEcCtD
Lidocaine—Urticaria—Prednisone—prostate cancer	2.5e-05	0.000317	CcSEcCtD
Lidocaine—Confusional state—Epirubicin—prostate cancer	2.48e-05	0.000314	CcSEcCtD
Lidocaine—Oedema—Epirubicin—prostate cancer	2.46e-05	0.000312	CcSEcCtD
Lidocaine—Anaphylactic shock—Epirubicin—prostate cancer	2.46e-05	0.000312	CcSEcCtD
Lidocaine—Loss of consciousness—Doxorubicin—prostate cancer	2.45e-05	0.000311	CcSEcCtD
Lidocaine—Shock—Epirubicin—prostate cancer	2.42e-05	0.000307	CcSEcCtD
Lidocaine—Convulsion—Doxorubicin—prostate cancer	2.41e-05	0.000306	CcSEcCtD
Lidocaine—Nervous system disorder—Epirubicin—prostate cancer	2.41e-05	0.000306	CcSEcCtD
Lidocaine—Dizziness—Docetaxel—prostate cancer	2.41e-05	0.000306	CcSEcCtD
Lidocaine—Hypertension—Doxorubicin—prostate cancer	2.41e-05	0.000305	CcSEcCtD
Lidocaine—Hyperhidrosis—Epirubicin—prostate cancer	2.38e-05	0.000301	CcSEcCtD
Lidocaine—Chest pain—Doxorubicin—prostate cancer	2.37e-05	0.000301	CcSEcCtD
Lidocaine—Anxiety—Doxorubicin—prostate cancer	2.36e-05	0.0003	CcSEcCtD
Lidocaine—Dizziness—Capecitabine—prostate cancer	2.33e-05	0.000296	CcSEcCtD
Lidocaine—Vomiting—Docetaxel—prostate cancer	2.32e-05	0.000294	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisone—prostate cancer	2.32e-05	0.000294	CcSEcCtD
Lidocaine—Rash—Docetaxel—prostate cancer	2.3e-05	0.000291	CcSEcCtD
Lidocaine—Hypotension—Epirubicin—prostate cancer	2.3e-05	0.000291	CcSEcCtD
Lidocaine—Dermatitis—Docetaxel—prostate cancer	2.3e-05	0.000291	CcSEcCtD
Lidocaine—Confusional state—Doxorubicin—prostate cancer	2.29e-05	0.000291	CcSEcCtD
Lidocaine—Headache—Docetaxel—prostate cancer	2.28e-05	0.00029	CcSEcCtD
Lidocaine—Oedema—Doxorubicin—prostate cancer	2.27e-05	0.000288	CcSEcCtD
Lidocaine—Anaphylactic shock—Doxorubicin—prostate cancer	2.27e-05	0.000288	CcSEcCtD
Lidocaine—Asthenia—Prednisone—prostate cancer	2.26e-05	0.000286	CcSEcCtD
Lidocaine—Vomiting—Capecitabine—prostate cancer	2.24e-05	0.000284	CcSEcCtD
Lidocaine—Shock—Doxorubicin—prostate cancer	2.24e-05	0.000284	CcSEcCtD
Lidocaine—Nervous system disorder—Doxorubicin—prostate cancer	2.23e-05	0.000283	CcSEcCtD
Lidocaine—Rash—Capecitabine—prostate cancer	2.22e-05	0.000282	CcSEcCtD
Lidocaine—Dermatitis—Capecitabine—prostate cancer	2.22e-05	0.000282	CcSEcCtD
Lidocaine—Headache—Capecitabine—prostate cancer	2.21e-05	0.00028	CcSEcCtD
Lidocaine—Paraesthesia—Epirubicin—prostate cancer	2.21e-05	0.00028	CcSEcCtD
Lidocaine—Hyperhidrosis—Doxorubicin—prostate cancer	2.2e-05	0.000279	CcSEcCtD
Lidocaine—Dyspnoea—Epirubicin—prostate cancer	2.19e-05	0.000278	CcSEcCtD
Lidocaine—Somnolence—Epirubicin—prostate cancer	2.19e-05	0.000277	CcSEcCtD
Lidocaine—Nausea—Docetaxel—prostate cancer	2.16e-05	0.000274	CcSEcCtD
Lidocaine—Hypotension—Doxorubicin—prostate cancer	2.13e-05	0.000269	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.12e-05	0.000269	CcSEcCtD
Lidocaine—Pain—Epirubicin—prostate cancer	2.1e-05	0.000267	CcSEcCtD
Lidocaine—Nausea—Capecitabine—prostate cancer	2.1e-05	0.000266	CcSEcCtD
Lidocaine—Dizziness—Prednisone—prostate cancer	2.08e-05	0.000264	CcSEcCtD
Lidocaine—Paraesthesia—Doxorubicin—prostate cancer	2.04e-05	0.000259	CcSEcCtD
Lidocaine—Dyspnoea—Doxorubicin—prostate cancer	2.03e-05	0.000257	CcSEcCtD
Lidocaine—Feeling abnormal—Epirubicin—prostate cancer	2.03e-05	0.000257	CcSEcCtD
Lidocaine—Somnolence—Doxorubicin—prostate cancer	2.02e-05	0.000256	CcSEcCtD
Lidocaine—Vomiting—Prednisone—prostate cancer	2e-05	0.000253	CcSEcCtD
Lidocaine—Rash—Prednisone—prostate cancer	1.98e-05	0.000251	CcSEcCtD
Lidocaine—Dermatitis—Prednisone—prostate cancer	1.98e-05	0.000251	CcSEcCtD
Lidocaine—Headache—Prednisone—prostate cancer	1.97e-05	0.00025	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.96e-05	0.000249	CcSEcCtD
Lidocaine—Urticaria—Epirubicin—prostate cancer	1.95e-05	0.000248	CcSEcCtD
Lidocaine—Pain—Doxorubicin—prostate cancer	1.95e-05	0.000247	CcSEcCtD
Lidocaine—Feeling abnormal—Doxorubicin—prostate cancer	1.87e-05	0.000238	CcSEcCtD
Lidocaine—Nausea—Prednisone—prostate cancer	1.87e-05	0.000237	CcSEcCtD
Lidocaine—Hypersensitivity—Epirubicin—prostate cancer	1.81e-05	0.00023	CcSEcCtD
Lidocaine—Urticaria—Doxorubicin—prostate cancer	1.81e-05	0.000229	CcSEcCtD
Lidocaine—Asthenia—Epirubicin—prostate cancer	1.76e-05	0.000224	CcSEcCtD
Lidocaine—Hypersensitivity—Doxorubicin—prostate cancer	1.68e-05	0.000212	CcSEcCtD
Lidocaine—Asthenia—Doxorubicin—prostate cancer	1.63e-05	0.000207	CcSEcCtD
Lidocaine—Dizziness—Epirubicin—prostate cancer	1.63e-05	0.000206	CcSEcCtD
Lidocaine—Vomiting—Epirubicin—prostate cancer	1.56e-05	0.000198	CcSEcCtD
Lidocaine—Rash—Epirubicin—prostate cancer	1.55e-05	0.000197	CcSEcCtD
Lidocaine—Dermatitis—Epirubicin—prostate cancer	1.55e-05	0.000196	CcSEcCtD
Lidocaine—Headache—Epirubicin—prostate cancer	1.54e-05	0.000195	CcSEcCtD
Lidocaine—Dizziness—Doxorubicin—prostate cancer	1.5e-05	0.000191	CcSEcCtD
Lidocaine—Nausea—Epirubicin—prostate cancer	1.46e-05	0.000185	CcSEcCtD
Lidocaine—Vomiting—Doxorubicin—prostate cancer	1.45e-05	0.000183	CcSEcCtD
Lidocaine—Rash—Doxorubicin—prostate cancer	1.43e-05	0.000182	CcSEcCtD
Lidocaine—Dermatitis—Doxorubicin—prostate cancer	1.43e-05	0.000182	CcSEcCtD
Lidocaine—Headache—Doxorubicin—prostate cancer	1.42e-05	0.000181	CcSEcCtD
Lidocaine—Nausea—Doxorubicin—prostate cancer	1.35e-05	0.000171	CcSEcCtD
Lidocaine—ABCB1—Metabolism—COMT—prostate cancer	9.66e-07	1.18e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAP2K1—prostate cancer	9.61e-07	1.17e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTP1—prostate cancer	9.61e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP1A1—prostate cancer	9.61e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNG5—prostate cancer	9.59e-07	1.17e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CD—prostate cancer	9.55e-07	1.16e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CAV1—prostate cancer	9.54e-07	1.16e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ERCC2—prostate cancer	9.53e-07	1.16e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—SRC—prostate cancer	9.53e-07	1.16e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC5A5—prostate cancer	9.53e-07	1.16e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ITPR1—prostate cancer	9.46e-07	1.15e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—RXRA—prostate cancer	9.45e-07	1.15e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SERPINE1—prostate cancer	9.45e-07	1.15e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—RXRA—prostate cancer	9.37e-07	1.14e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—prostate cancer	9.35e-07	1.14e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP2E1—prostate cancer	9.3e-07	1.13e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NCOA3—prostate cancer	9.23e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CB—prostate cancer	9.21e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NQO1—prostate cancer	9.2e-07	1.12e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—STAT3—prostate cancer	9.19e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NOS3—prostate cancer	9.15e-07	1.11e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGF2—prostate cancer	9.15e-07	1.11e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—prostate cancer	9.13e-07	1.11e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.11e-07	1.11e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—COMT—prostate cancer	9.1e-07	1.11e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TH—prostate cancer	9.07e-07	1.1e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTP1—prostate cancer	9.06e-07	1.1e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—COMT—prostate cancer	9.02e-07	1.1e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOS3—prostate cancer	9.02e-07	1.1e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	9.01e-07	1.1e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTP1—prostate cancer	8.98e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP3A4—prostate cancer	8.97e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—prostate cancer	8.96e-07	1.09e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—TYMS—prostate cancer	8.94e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.93e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ITPR1—prostate cancer	8.91e-07	1.09e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CG—prostate cancer	8.89e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ITPR1—prostate cancer	8.84e-07	1.08e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—prostate cancer	8.83e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP1B1—prostate cancer	8.82e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HPGDS—prostate cancer	8.81e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPARA—prostate cancer	8.79e-07	1.07e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JAK2—prostate cancer	8.77e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2C19—prostate cancer	8.75e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CG—prostate cancer	8.69e-07	1.06e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.69e-07	1.06e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—LPL—prostate cancer	8.67e-07	1.06e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—prostate cancer	8.59e-07	1.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MDM2—prostate cancer	8.56e-07	1.04e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—prostate cancer	8.54e-07	1.04e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTT1—prostate cancer	8.54e-07	1.04e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ACHE—prostate cancer	8.54e-07	1.04e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GGT1—prostate cancer	8.54e-07	1.04e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—prostate cancer	8.54e-07	1.04e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—prostate cancer	8.52e-07	1.04e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—prostate cancer	8.45e-07	1.03e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CB—prostate cancer	8.44e-07	1.03e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2A6—prostate cancer	8.44e-07	1.03e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—prostate cancer	8.44e-07	1.03e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—TYMS—prostate cancer	8.42e-07	1.03e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—INS—prostate cancer	8.42e-07	1.02e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NCOA1—prostate cancer	8.41e-07	1.02e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP1A1—prostate cancer	8.37e-07	1.02e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—prostate cancer	8.37e-07	1.02e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—TYMS—prostate cancer	8.35e-07	1.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CB—prostate cancer	8.33e-07	1.01e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—prostate cancer	8.32e-07	1.01e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ERCC2—prostate cancer	8.3e-07	1.01e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP19A1—prostate cancer	8.29e-07	1.01e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CAV1—prostate cancer	8.26e-07	1.01e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—prostate cancer	8.25e-07	1e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CREBBP—prostate cancer	8.24e-07	1e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—INS—prostate cancer	8.23e-07	1e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKR1C3—prostate cancer	8.21e-07	1e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PRKACB—prostate cancer	8.17e-07	9.95e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—LPL—prostate cancer	8.17e-07	9.95e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—LPL—prostate cancer	8.1e-07	9.86e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP17A1—prostate cancer	8.09e-07	9.85e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CREBBP—prostate cancer	8.06e-07	9.81e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—RXRA—prostate cancer	8e-07	9.74e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCL8—prostate cancer	8e-07	9.74e-06	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTEN—prostate cancer	7.96e-07	9.69e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.9e-07	9.61e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP1A1—prostate cancer	7.89e-07	9.61e-06	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—prostate cancer	7.89e-07	9.6e-06	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—prostate cancer	7.85e-07	9.56e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ERCC2—prostate cancer	7.83e-07	9.53e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP1A1—prostate cancer	7.82e-07	9.52e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CD—prostate cancer	7.82e-07	9.52e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1B—prostate cancer	7.81e-07	9.51e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—prostate cancer	7.81e-07	9.5e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.78e-07	9.48e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ERCC2—prostate cancer	7.76e-07	9.45e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—COMT—prostate cancer	7.71e-07	9.39e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NCOA2—prostate cancer	7.71e-07	9.38e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTP1—prostate cancer	7.67e-07	9.34e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARA—prostate cancer	7.66e-07	9.32e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—prostate cancer	7.66e-07	9.32e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—prostate cancer	7.65e-07	9.31e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CD—prostate cancer	7.64e-07	9.3e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—prostate cancer	7.61e-07	9.26e-06	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—EP300—prostate cancer	7.59e-07	9.24e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ITPR1—prostate cancer	7.55e-07	9.19e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CG—prostate cancer	7.53e-07	9.17e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—prostate cancer	7.45e-07	9.07e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.42e-07	9.04e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NOS3—prostate cancer	7.38e-07	8.99e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—prostate cancer	7.38e-07	8.99e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—prostate cancer	7.36e-07	8.96e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC5A5—prostate cancer	7.35e-07	8.95e-06	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTEN—prostate cancer	7.3e-07	8.88e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—prostate cancer	7.29e-07	8.88e-06	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—prostate cancer	7.25e-07	8.82e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—prostate cancer	7.24e-07	8.81e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARA—prostate cancer	7.22e-07	8.79e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NOS3—prostate cancer	7.21e-07	8.78e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1A—prostate cancer	7.21e-07	8.78e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CAV1—prostate cancer	7.2e-07	8.77e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTEN—prostate cancer	7.19e-07	8.76e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2E1—prostate cancer	7.18e-07	8.74e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARA—prostate cancer	7.15e-07	8.71e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TYMS—prostate cancer	7.13e-07	8.68e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—INS—prostate cancer	7.13e-07	8.68e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NQO1—prostate cancer	7.1e-07	8.64e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—prostate cancer	7.05e-07	8.58e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—prostate cancer	7.02e-07	8.54e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TH—prostate cancer	7e-07	8.52e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CREBBP—prostate cancer	6.98e-07	8.5e-06	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—EP300—prostate cancer	6.96e-07	8.47e-06	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—prostate cancer	6.95e-07	8.46e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—LPL—prostate cancer	6.92e-07	8.43e-06	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—prostate cancer	6.9e-07	8.4e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EP300—prostate cancer	6.86e-07	8.35e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CB—prostate cancer	6.81e-07	8.3e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.81e-07	8.29e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CAV1—prostate cancer	6.78e-07	8.26e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—prostate cancer	6.75e-07	8.22e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CAV1—prostate cancer	6.73e-07	8.19e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP1A1—prostate cancer	6.68e-07	8.14e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SRC—prostate cancer	6.67e-07	8.12e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CB—prostate cancer	6.66e-07	8.11e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ERCC2—prostate cancer	6.63e-07	8.07e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CD—prostate cancer	6.62e-07	8.06e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—prostate cancer	6.6e-07	8.03e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GGT1—prostate cancer	6.59e-07	8.03e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CG—prostate cancer	6.56e-07	7.98e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—prostate cancer	6.5e-07	7.91e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NCOA1—prostate cancer	6.49e-07	7.91e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT3—prostate cancer	6.43e-07	7.83e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.43e-07	7.82e-06	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—prostate cancer	6.42e-07	7.81e-06	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—prostate cancer	6.41e-07	7.81e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP19A1—prostate cancer	6.4e-07	7.79e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NOS3—prostate cancer	6.25e-07	7.61e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—prostate cancer	6.23e-07	7.59e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—INS—prostate cancer	6.21e-07	7.56e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CG—prostate cancer	6.18e-07	7.52e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—RXRA—prostate cancer	6.18e-07	7.52e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CG—prostate cancer	6.13e-07	7.46e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARA—prostate cancer	6.11e-07	7.44e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CREBBP—prostate cancer	6.08e-07	7.4e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—prostate cancer	5.98e-07	7.28e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—prostate cancer	5.96e-07	7.26e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—COMT—prostate cancer	5.95e-07	7.24e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTP1—prostate cancer	5.92e-07	7.21e-06	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—prostate cancer	5.92e-07	7.21e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTEN—prostate cancer	5.89e-07	7.17e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—INS—prostate cancer	5.85e-07	7.12e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ITPR1—prostate cancer	5.83e-07	7.09e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—INS—prostate cancer	5.8e-07	7.06e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CB—prostate cancer	5.77e-07	7.02e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CD—prostate cancer	5.77e-07	7.02e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTEN—prostate cancer	5.75e-07	7.01e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CAV1—prostate cancer	5.75e-07	7e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CREBBP—prostate cancer	5.73e-07	6.98e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—prostate cancer	5.72e-07	6.96e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CREBBP—prostate cancer	5.68e-07	6.92e-06	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—prostate cancer	5.62e-07	6.84e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—EP300—prostate cancer	5.61e-07	6.84e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—prostate cancer	5.52e-07	6.73e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TYMS—prostate cancer	5.51e-07	6.7e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.49e-07	6.69e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—EP300—prostate cancer	5.49e-07	6.68e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NOS3—prostate cancer	5.44e-07	6.63e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—prostate cancer	5.44e-07	6.63e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.43e-07	6.61e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CD—prostate cancer	5.39e-07	6.56e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LPL—prostate cancer	5.34e-07	6.5e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CG—prostate cancer	5.24e-07	6.37e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.16e-07	6.28e-06	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—prostate cancer	5.15e-07	6.27e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NOS3—prostate cancer	5.13e-07	6.25e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ERCC2—prostate cancer	5.12e-07	6.23e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NOS3—prostate cancer	5.09e-07	6.19e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—prostate cancer	5.08e-07	6.18e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CB—prostate cancer	5.03e-07	6.12e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTEN—prostate cancer	4.98e-07	6.07e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—prostate cancer	4.98e-07	6.06e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—INS—prostate cancer	4.96e-07	6.03e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—prostate cancer	4.91e-07	5.98e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CREBBP—prostate cancer	4.85e-07	5.91e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—prostate cancer	4.81e-07	5.86e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—EP300—prostate cancer	4.75e-07	5.79e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.74e-07	5.77e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARA—prostate cancer	4.72e-07	5.74e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CB—prostate cancer	4.69e-07	5.72e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—prostate cancer	4.69e-07	5.71e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—prostate cancer	4.65e-07	5.66e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CD—prostate cancer	4.6e-07	5.6e-06	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—prostate cancer	4.59e-07	5.59e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—prostate cancer	4.49e-07	5.47e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CAV1—prostate cancer	4.44e-07	5.4e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NOS3—prostate cancer	4.35e-07	5.29e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTEN—prostate cancer	4.34e-07	5.29e-06	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—prostate cancer	4.21e-07	5.12e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—prostate cancer	4.15e-07	5.06e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—prostate cancer	4.15e-07	5.05e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—EP300—prostate cancer	4.14e-07	5.04e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTEN—prostate cancer	4.09e-07	4.98e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—prostate cancer	4.06e-07	4.94e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTEN—prostate cancer	4.06e-07	4.94e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.04e-07	4.92e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CB—prostate cancer	4.01e-07	4.88e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—prostate cancer	3.98e-07	4.84e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—EP300—prostate cancer	3.9e-07	4.75e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—EP300—prostate cancer	3.87e-07	4.71e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—INS—prostate cancer	3.82e-07	4.66e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CREBBP—prostate cancer	3.75e-07	4.56e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.55e-07	4.32e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.52e-07	4.28e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTEN—prostate cancer	3.47e-07	4.22e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—prostate cancer	3.39e-07	4.13e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NOS3—prostate cancer	3.35e-07	4.08e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—prostate cancer	3.32e-07	4.04e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—EP300—prostate cancer	3.31e-07	4.03e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.1e-07	3.77e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.07e-07	3.74e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—prostate cancer	3.06e-07	3.73e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.89e-07	3.51e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—prostate cancer	2.87e-07	3.5e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.86e-07	3.48e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTEN—prostate cancer	2.68e-07	3.26e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—EP300—prostate cancer	2.55e-07	3.11e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—prostate cancer	2.5e-07	3.05e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.45e-07	2.98e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—prostate cancer	2.36e-07	2.87e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—prostate cancer	2.34e-07	2.85e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—prostate cancer	2e-07	2.43e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.89e-07	2.3e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—prostate cancer	1.54e-07	1.88e-06	CbGpPWpGaD
